MD SIMULATIONS OF DESIGNED HIV INHIBITORS
MD SIMULATIONS OF DESIGNED HIV INHIBITORS
批准号:
8171922
负责人:
CHRISTOPHER ASHMAN
金额:
$0.11万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-08-01 至 2013-07-31
关键词:
Active SitesAlgorithmsAmberBehaviorCharacteristicsComputer Retrieval of Information on Scientific Projects DatabaseDrug resistanceEducational process of instructingEnzyme InhibitionEnzymesFullerenesFundingGrantHIV ProteaseHIV-1 proteaseHydrocarbonsIndividualInstitutionInvestigationLeadLearningLigandsMolecularMutateNaturePeptide HydrolasesPharmaceutical PreparationsPropertyProtease InhibitorPublishingReportingResearchResearch PersonnelResourcesRunningSamplingShapesSolubilitySourceSurfaceTestingTimeUnited States National Institutes of HealthViralViral Load resultVirusWaterWorkaqueousbasecomputer studiesdesigninhibitor/antagonistinterestnovelsimulation
中文摘要
这个子项目是众多研究子项目之一
英文摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
The HIV-1 protease is a basket-shaped viral enzyme that participates in the
maturation of the virus. Inhibition of this enzyme reduces the viral load in infected
individuals. While several drugs are currently available that inhibit the function of the
HIV protease, the need to design and develop new, novel drugs is imperative as the
protease continues to rapidly mutate into drug-resistant forms. In the early 1990s
Friedman and co-workers published two reports describing fullerene and fullerene
derivatives (buckyballs) as inhibitors of HIV-1 protease as they are precisely the right
size and shape to fit into and inhibit the active site. Unfortunately, this work did not
lead to viable drugs as the aqueous solubility characteristics of the hydrocarbon-
based buckyballs proved to be an insurmountable challenge. Recently we have
published a computational study of the molecular behavior of an important class of
new polyhedral molecules with different hydrophobic/hydrophilic properties. While
studying these molecules we realized that their size and shape is quite comparable
to C60 while the nature of their bonds allows them to be much more water soluble.
We are interested in performing a computational investigation of the feasibility of
using these molecules as HIV-1 protease inhibitors. Previously, we have performed
MD simulations of the HIV protease sans any ligands; with C60; and in complexation
with our molecules, using stochastic dynamics as implemented in MacroModel (serial)
on the OPLS2005/GBSA(water) surface. We would like to verify our results using a
different force field and sampling algorithm and so we have been teaching ourselves
to properly use the AMBER and Desmond simulation packages. We are requesting
30,0000 units in order to run AMBER and Desmond on multiple processors shortening
the testing and learning times.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
MD SIMULATIONS OF DESIGNED HIV INHIBITORS
-
批准号:8364306
-
项目类别:
-
资助金额:$0.2万
-
财政年份:2011
-
负责人:CHRISTOPHER ASHMAN
-
依托单位:
海外基金